Latest News and Press Releases

Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Analysis Report By Indication (Cancer, Infectious Diseases, Metabolic...

Eascra Biotech announced their first commercial lab, a preclinical startup space within the Massachusetts Biomedical Initiatives facility in Worcester, MA.

MAINZ, Deutschland, 24. April 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der diesjährigen Jahrestagung der American Association for Cancer Research...

MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified oncology pipeline, including mRNA cancer...

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Synthetic Biology Platforms Market by Offering (DNA Sequencing, DNA Synthesis, mRNA Synthesis), Application (Antibody Discovery & NGS, Cell &...

Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: siRNA gene silencing" report has been added to ResearchAndMarkets.com's offering. In terms of deals, there have been 334 deals...

JUPITER, Fla., March 12, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient...

Dyadic Provides Business Update Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

New York, USA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Market Overview The market for mRNA vaccines and therapeutics is poised to grow, according to the latest research study by Polaris Market Research....

VG801 is the first FDA IND clearance for novel mRNA trans-splicing gene therapy, delivering the full-length functional ABCA4 gene to target the genetic root cause of retinal dystrophies associated...